Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19
Progressive decrease in the weight and functional reserve of β-cells is one of the main pathogenetic mechanisms of development of type 2 diabetes mellitus (DM2). The rate of progression of these processes is strictly individual, which largely determines the course of DM2 and the effectivene...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/62260d1579e642eebf8122da7935c08c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:62260d1579e642eebf8122da7935c08c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:62260d1579e642eebf8122da7935c08c2021-11-14T09:00:23ZHyperglycemia and possible mechanisms of β-cell damage in patients with COVID-192072-03512072-037810.14341/DM12485https://doaj.org/article/62260d1579e642eebf8122da7935c08c2020-08-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/12485https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Progressive decrease in the weight and functional reserve of β-cells is one of the main pathogenetic mechanisms of development of type 2 diabetes mellitus (DM2). The rate of progression of these processes is strictly individual, which largely determines the course of DM2 and the effectiveness of the therapy. As a rule, apoptosis and necrosis are the main mechanisms of β-cell damage and death in CD2. At the same time, recent studies allow us to consider the destruction and death of β-cells as the outcome of other types of programmed cell death (PCG), the role of innate immunity in the Genesis of CD2 IS actively discussed. This article provides an overview of the data of domestic and foreign literature of recent years regarding the molecular, intracellular characteristics of different types of β-cell PCG in CD2. The results of studies aimed at studying the possible factors and processes leading to their launch are presented.Z. A. KalmykovaI. V. KononenkoI. A. SklyanikM. V. ShestakovaN. G. MokryshevaEndocrinology Research Centrearticlecovid-19sars-cov-2stress hyperglycemiaβ-cell“cytokine storm”Nutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 23, Iss 3, Pp 229-234 (2020) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN RU |
topic |
covid-19 sars-cov-2 stress hyperglycemia β-cell “cytokine storm” Nutritional diseases. Deficiency diseases RC620-627 |
spellingShingle |
covid-19 sars-cov-2 stress hyperglycemia β-cell “cytokine storm” Nutritional diseases. Deficiency diseases RC620-627 Z. A. Kalmykova I. V. Kononenko I. A. Sklyanik M. V. Shestakova N. G. Mokrysheva Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19 |
description |
Progressive decrease in the weight and functional reserve of β-cells is one of the main pathogenetic mechanisms of development of type 2 diabetes mellitus (DM2). The rate of progression of these processes is strictly individual, which largely determines the course of DM2 and the effectiveness of the therapy. As a rule, apoptosis and necrosis are the main mechanisms of β-cell damage and death in CD2. At the same time, recent studies allow us to consider the destruction and death of β-cells as the outcome of other types of programmed cell death (PCG), the role of innate immunity in the Genesis of CD2 IS actively discussed. This article provides an overview of the data of domestic and foreign literature of recent years regarding the molecular, intracellular characteristics of different types of β-cell PCG in CD2. The results of studies aimed at studying the possible factors and processes leading to their launch are presented. |
format |
article |
author |
Z. A. Kalmykova I. V. Kononenko I. A. Sklyanik M. V. Shestakova N. G. Mokrysheva |
author_facet |
Z. A. Kalmykova I. V. Kononenko I. A. Sklyanik M. V. Shestakova N. G. Mokrysheva |
author_sort |
Z. A. Kalmykova |
title |
Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19 |
title_short |
Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19 |
title_full |
Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19 |
title_fullStr |
Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19 |
title_full_unstemmed |
Hyperglycemia and possible mechanisms of β-cell damage in patients with COVID-19 |
title_sort |
hyperglycemia and possible mechanisms of β-cell damage in patients with covid-19 |
publisher |
Endocrinology Research Centre |
publishDate |
2020 |
url |
https://doaj.org/article/62260d1579e642eebf8122da7935c08c |
work_keys_str_mv |
AT zakalmykova hyperglycemiaandpossiblemechanismsofbcelldamageinpatientswithcovid19 AT ivkononenko hyperglycemiaandpossiblemechanismsofbcelldamageinpatientswithcovid19 AT iasklyanik hyperglycemiaandpossiblemechanismsofbcelldamageinpatientswithcovid19 AT mvshestakova hyperglycemiaandpossiblemechanismsofbcelldamageinpatientswithcovid19 AT ngmokrysheva hyperglycemiaandpossiblemechanismsofbcelldamageinpatientswithcovid19 |
_version_ |
1718429466586251264 |